Literature DB >> 16557535

Role of beta-catenin in the adult liver.

Frank J Gonzalez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16557535      PMCID： PMC1440290          DOI： 10.1002/hep.21154

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  23 in total

1.  Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.

Authors:  J Corchero; S Pimprale; S Kimura; F J Gonzalez
Journal:  Pharmacogenetics       Date:  2001-02

2.  Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.

Authors:  Xinping Tan; Udayan Apte; Amanda Micsenyi; Emorphia Kotsagrelos; Jian-Hua Luo; Sarangarajan Ranganathan; Dulabh K Monga; Aaron Bell; George K Michalopoulos; Satdarshan P S Monga
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration.

Authors:  S P Monga; P Pediaditakis; K Mule; D B Stolz; G K Michalopoulos
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

4.  Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1alpha)-deficient mice.

Authors:  Connie Cheung; Taro E Akiyama; Gen Kudo; Frank J Gonzalez
Journal:  Biochem Pharmacol       Date:  2003-11-15       Impact factor: 5.858

5.  A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.

Authors:  Sandra Loeppen; Christoph Koehle; Albrecht Buchmann; Michael Schwarz
Journal:  Carcinogenesis       Date:  2004-10-07       Impact factor: 4.944

6.  Beta-catenin is temporally regulated during normal liver development.

Authors:  Amanda Micsenyi; Xinping Tan; Tamara Sneddon; Jian-Hua Luo; George K Michalopoulos; Satdarshan P S Monga
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

7.  New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism.

Authors:  Axelle Cadoret; Christine Ovejero; Benoit Terris; Evelyne Souil; Laurence Lévy; Wouter H Lamers; Jan Kitajewski; Axel Kahn; Christine Perret
Journal:  Oncogene       Date:  2002-11-28       Impact factor: 9.867

Review 8.  The significance of the Wnt pathway in the pathology of human cancers.

Authors:  Rooshdiya Karim; Gary Tse; Thomas Putti; Richard Scolyer; Soon Lee
Journal:  Pathology       Date:  2004-04       Impact factor: 5.306

9.  Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification.

Authors:  Satdarshan P S Monga; Hardarshan K Monga; Xinping Tan; Karen Mulé; Peter Pediaditakis; George K Michalopoulos
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

10.  Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice.

Authors:  Shigeki Sekine; Billy Yu-Ang Lan; Melanie Bedolli; Sandy Feng; Matthias Hebrok
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425
View more
  6 in total

1.  Wnt/beta-catenin signaling in hepatic organogenesis.

Authors:  Kari Nejak-Bowen; Satdarshan Ps Monga
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

2.  Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma.

Authors:  Soumya C Iyer; Ashidha Gopal; Devaraj Halagowder
Journal:  Mol Cell Biochem       Date:  2015-06-24       Impact factor: 3.396

3.  Dickkopfs and Wnt/β-catenin signalling in liver cancer.

Authors:  Sarwat Fatima; Nikki P Lee; John M Luk
Journal:  World J Clin Oncol       Date:  2011-08-10

4.  Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease.

Authors:  Ursula J Lemberger; Claudia D Fuchs; Matthias Karer; Stefanie Haas; Tatjana Stojakovic; Christian Schöfer; Hanns-Ulrich Marschall; Fritz Wrba; Makoto M Taketo; Gerda Egger; Michael Trauner; Christoph H Österreicher
Journal:  Oncotarget       Date:  2016-12-27

5.  Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes.

Authors:  Chih-Li Chen; Yu-Shuen Tsai; Yen-Hua Huang; Yuh-Jin Liang; Ya-Yun Sun; Chien-Wei Su; Gar-Yang Chau; Yi-Chen Yeh; Yung-Sheng Chang; Jui-Ting Hu; Jaw-Ching Wu
Journal:  Hepatol Commun       Date:  2018-09-28

Review 6.  Targeting the Wnt pathways for therapies.

Authors:  Artem Blagodatski; Dmitry Poteryaev; Vladimir L Katanaev
Journal:  Mol Cell Ther       Date:  2014-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.